CHASTLETON MEDICAL GROUP — All Prescriptions & Medications — Page 2
Practice Code: A83036 | DURHAM, DH1 5BH
Showing results 51-100 of 660
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Isosorbide mononitrate | 1,032 | 52.6K | £2.7K | +56.1% ▲ |
| Enalapril maleate | 1,004 | 65.0K | £2.4K | +458.8% ▲ |
| Senna | 993 | 38.2K | £912 | +65.0% ▲ |
| Docusate sodium | 990 | 61.4K | £4.4K | +167.0% ▲ |
| Glucose blood testing reagents | 979 | 118.8K | £14.5K | +24.1% ▲ |
| Trazodone hydrochloride | 974 | 39.6K | £2.0K | +376.5% ▲ |
| Bendroflumethiazide | 972 | 46.9K | £773 | +25.7% ▲ |
| Memantine hydrochloride | 960 | 21.9K | £8.7K | +190.6% ▲ |
| Doxycycline hyclate | 945 | 11.5K | £1.1K | +84.4% ▲ |
| Other emollient preparations | 934 | 498.3K | £6.5K | +55.5% ▲ |
| Indapamide | 918 | 42.9K | £1.2K | +6.4% ▲ |
| Ibuprofen | 902 | 84.7K | £3.7K | +77.3% ▲ |
| Naproxen | 864 | 56.0K | £2.8K | -12.5% ▼ |
| Warfarin sodium | 856 | 53.2K | £1.8K | +81.5% ▲ |
| Ezetimibe | 829 | 29.9K | £5.2K | +16.5% ▲ |
| Ferrous sulfate | 813 | 34.6K | £1.2K | +58.1% ▲ |
| Duloxetine hydrochloride | 801 | 23.5K | £2.8K | +26.0% ▲ |
| Ferrous fumarate | 801 | 38.0K | £1.6K | +10.5% ▲ |
| Solifenacin | 772 | 22.7K | £903 | +61.8% ▲ |
| Betamethasone valerate | 766 | 60.5K | £3.4K | +99.0% ▲ |
| 758 | 1,830 | £66.6K | +39.1% ▲ | |
| Hydrocortisone | 740 | 23.6K | £5.3K | +65.0% ▲ |
| Latanoprost | 728 | 9,008 | £3.6K | +50.0% ▲ |
| Perindopril erbumine | 725 | 26.5K | £1.9K | +36.6% ▲ |
| Insulin aspart | 721 | 4,684 | £30.4K | +89.4% ▲ |
| 700 | 113.6K | £6.4K | +47.5% ▲ | |
| Nitrofurantoin | 679 | 8,730 | £5.0K | +42.3% ▲ |
| Felodipine | 675 | 27.8K | £4.5K | +13.7% ▲ |
| Flucloxacillin sodium | 653 | 29.3K | £1.5K | +45.2% ▲ |
| Mirabegron | 643 | 17.9K | £16.5K | +60.1% ▲ |
| Beclometasone dipropionate | 628 | 709 | £2.2K | +192.0% ▲ |
| Gliclazide | 626 | 56.8K | £1.4K | -26.4% ▼ |
| Alginic acid compound preparations | 620 | 367.7K | £4.3K | +5.8% ▲ |
| Rivaroxaban | 620 | 25.1K | £16.3K | +1.3% vs avg |
| Budesonide | 600 | 982 | £19.5K | +10.7% ▲ |
| Hydroxocobalamin | 600 | 624 | £1.3K | +24.7% ▲ |
| Carbocisteine | 585 | 64.6K | £1.6K | +9.6% ▲ |
| Quinine sulfate | 568 | 12.7K | £2.1K | +96.2% ▲ |
| Diclofenac diethyl | 565 | 56.2K | £4.4K | +59.1% ▲ |
| Betahistine hydrochloride | 555 | 46.2K | £1.6K | +132.5% ▲ |
| Dapagliflozin | 554 | 19.3K | £23.9K | -55.8% ▼ |
| 545 | 1,180 | £1.2K | +147.3% ▲ | |
| Levetiracetam | 511 | 52.5K | £5.0K | +11.6% ▲ |
| Estradiol | 505 | 102.5K | £13.5K | -38.5% ▼ |
| Co-beneldopa (Benserazide/levodopa) | 504 | 64.2K | £4.3K | +233.4% ▲ |
| Carbomer 940/980 | 493 | 12.8K | £2.6K | +223.8% ▲ |
| Digoxin | 486 | 15.8K | £1.2K | +28.4% ▲ |
| Loperamide hydrochloride | 484 | 40.0K | £5.4K | +107.8% ▲ |
| Mebeverine hydrochloride | 467 | 37.5K | £2.0K | +50.4% ▲ |
| Glyceryl trinitrate | 464 | 540 | £1.2K | +96.2% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.